IDENISE CABANAS: Open Payments
NPI 1184630758 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 86 payments from 24 companies in 2025. Trend: 2023 $1,666 · 2024 $1,733 · 2025 $1,917
Food & beverage: $1,917
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $254 |
| Amgen Inc. | 9 | $192 |
| Novo Nordisk Inc | 10 | $186 |
| PFIZER INC. | 6 | $177 |
| GlaxoSmithKline, LLC. | 8 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| Dexcom, Inc. | 4 | $97 |
| Abbott Laboratories | 3 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| Kowa Pharmaceuticals America, Inc. | 3 | $69 |
Products named: AIRSUPRA, OTEZLA, TRELEGY ELLIPTA, Ozempic, LEQVIO, Dexcom G6 Transmitter, ZAVZPRET, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
